Skip to main content

Comparison of a monoclonal with a polyclonal antibody-based enzyme immunoassay stool test in diagnosing Helicobacter pylori infection after eradication therapy

Journal of Gastroenterology volume 44, pages 713–716 (2009)Cite this article

Abstract

Background

Recently, a novel Helicobacter pylori stool antigen test (Testmate pylori antigen EIA) using monoclonal antibodies against H. pylori catalase has been developed commercially. This study assessed the diagnostic usefulness of the stool antigen test compared with a polyclonal enzyme immunoassay (HpSA test) after H. pylori eradication.

Methods

A total of 150 patients with H. pylori infection were treated by triple therapy with PPI and amoxicillin with either clarithromycin or metronidazole. H. pylori stool antigen was tested 4 and 8 weeks after eradication. The outcome of H. pylori eradication was assessed by urea breath test (UBT) 8 weeks after the end of therapy. Discordant results were followed by endoscopic examination.

Results

Of 150 patients enrolled, H. pylori status was negative in 122 cases and positive in 28 cases, assessed by the 13C-UBT. On the other hand, the monoclonal stool antigen test results were negative in 126 cases and positive in 24. The polyclonal stool test results were negative in 126 cases and positive in 22. The overall sensitivity and specificity of the monoclonal stool antigen test were 91.6% (95% CI 85.9–97.3%) and 98.4% (95% CI 97.3–99.5%). The overall sensitivity and specificity of the polyclonal stool antigen test were 87.0% (95% CI 86.9–94.0%) and 97.5% (95% CI 96.1–98.9%).

Conclusion

The new stool antigen test using monoclonal antibody is useful for the diagnosis of H. pylori eradication 4 weeks after the end of treatment.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

43,34 €

Price includes VAT (Finland)
Tax calculation will be finalised during checkout.

References

  1. Marshall BJ, Warren JR. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet. 1984;1(8390):1311–5.

    PubMed  Article  CAS  Google Scholar 

  2. Asaka M, Kato M, Sugiyama T, Satoh K, Kuwayama H, Fukuad Y, et al. Japan Helicobacter eradication Study Group. Follow-up survey of a large-scale multicenter, double-blind study of triple therapy with lansoprazole, amoxicillin, and clarithromycin for eradication of Helicobacter pylori in Japanese peptic ulcer patients. J Gastroenterol. 2003;38:339–47.

    Google Scholar 

  3. Take S, Mizuno M, Ishiki K, Nagahara Y, Yoshida T, Yokota K, et al. The effect of eradicating Helicobacter pylori on the development of gastric cancer in patients with peptic ulcer disease. Am J Gastroenterol. 2005;100:1037–42.

    PubMed  Article  Google Scholar 

  4. Gisbert JP, Pajares JM. Stool antigen test for the diagnosis of Helicobacter pylori infection; a systematic review. Helicobacter. 2004;9:347–68.

    PubMed  Article  Google Scholar 

  5. Suzuki N, Wakasugi M, Nakaya S, Kokubo N, Sato M, Kajiyama H, et al. Catalase, a specific antigen in the feces of human subjects infected with Helicobacter pylori. Clin Diagn Lab Immunol. 2002;9:784–8.

    PubMed  CAS  Google Scholar 

  6. Kato C, Sugiyama T, Sato K, Saito S, Kudara N, Abiko Y, et al. Appropriate cut-off value of 13C-urea breath test after eradication of Helicobacter pylori infection in Japan. J Gastroenterol Hepatol. 2003;18:1379–83.

    PubMed  Article  Google Scholar 

  7. Masoero G, Lombardo L, Della Monica P, Vicari S, Crocilla C, et al. Discrepancy between Helicobacter pylori stool antigen assay and urea breath test in the detection of Helicobacter pylori infection. Digest Liver Dis. 2000;32:285–90.

    Article  CAS  Google Scholar 

  8. Trevisani L, Sartori S, Galvani F, Rossi MR, Ruina M, Chiamenti C, et al. Evaluation of a new enzyme immunoassay for detecting Helicobacter pylori in feces: a prospective pilot study. Am J Gastroenteol. 1999;94:1830–3.

    Article  CAS  Google Scholar 

  9. Ishihara S, Kaji T, Kawamura A, Rumi MA, Sato H, Okuyama T, et al. Diagnostic accuracy of a new non-invasive enzyme immunoassay for detecting Helicobacter pylori in stools after eradication therapy. Aliment Pharmacol Ther. 2000;14:611–4.

    PubMed  Article  CAS  Google Scholar 

  10. Odaka T, Yamaguchi T, Koyama H, Saisho H, Nomura F. Evaluation of Helicobacter pylori stool antigen test for monitoring eradication therapy. Am J Gastroenterol. 2002;97:594–9.

    PubMed  Article  Google Scholar 

  11. Tanaka A, Watanabe K, Tokunaga K, Hoshina S, Imase K, Sugano H, et al. Evaluation of Helicobacter stool antigen test before and after eradication therapy. J Gastroenterol Hepatol. 2003;18:732–8.

    PubMed  Article  Google Scholar 

  12. Ohara S, Kato M, Asaka M, Toyota T. Studies of 13C-urea breath test for diagnosis of Helicobacter pylori infection in Japan. J Gastroenterol. 1998;33:6–13.

    PubMed  Article  CAS  Google Scholar 

  13. Tokunaga K, Watanabe K, Tanaka A, Sugano H, Imase K, Ishida H, et al. Evaluation of 13C-urea breath test to confirm eradication of Helicobacter pylori (in Japanese with English abstract). J Jpn Soc Gastroenterol. 2005;102:183–9.

    Google Scholar 

  14. Ito M, Tanaka S, Kim S, Tahara K, Kawamura Y, Sumii M, et al. A combination of the Helicobacter pylori stool antigen test and urea breath test is useful for clinical evaluation of eradication therapy: a multicenter study. J Gastroenterol Hepatol. 2005;20:1241–5.

    PubMed  Article  Google Scholar 

  15. Nagahara A, Miwa H, Ogawa K, Kurosaaw A, Ohkura R, Iida N, et al. Addition of metronidazole to rabeprazole-amoxicillin-clarithromycin regimen for Helicobacter pylori infection provides an excellent cure rates with five-day therapy. Helicobacter. 2000;5:88–93.

    PubMed  Article  CAS  Google Scholar 

  16. Costa F, Mumolo MG, Bellini M, Romano MR, Manghetti M, Paci A, et al. Post-treatment diagnosis accuracy of a new enzyme immunoassay to detect Helicobacter pylori in stools. Aliment Pharmacol Ther. 2001;15:395–401.

    PubMed  Article  CAS  Google Scholar 

Download references

Author information

Affiliations

  1. Department of Internal Medicine, Tokai University School of Medicine, 143 Shimokasuya, Isehara, Kanagawa, 259-1193, Japan

    Ryuzo Deguchi, Masashi Matsushima, Takayoshi Suzuki, Tetsuya Mine, Ryuki Fukuda, Makoto Nishina, Hideki Ozawa & Atsushi Takagi

Authors
  1. Ryuzo Deguchi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Masashi Matsushima
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Takayoshi Suzuki
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Tetsuya Mine
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Ryuki Fukuda
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Makoto Nishina
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Hideki Ozawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Atsushi Takagi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Atsushi Takagi.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Deguchi, R., Matsushima, M., Suzuki, T. et al. Comparison of a monoclonal with a polyclonal antibody-based enzyme immunoassay stool test in diagnosing Helicobacter pylori infection after eradication therapy. J Gastroenterol 44, 713–716 (2009). https://doi.org/10.1007/s00535-009-0069-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00535-009-0069-z

Keywords

  • Helicobacter pylori stool antigen test
  • Eradication therapy
  • Urea breath test